Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic Acid for Blood Loss in Hip Fracture Surgery
NCT02738073Unknown
- Sponsor
- Rothman Orthopaedics
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of tranexamic acid in hip fracture (2 arms), sponsored by Rothman Orthopaedics. Primary endpoint: Calculation of blood loss during the perioperative period. Status: unknown.
02
Drugs
tranexamic acid
03
Conditions
hip fracture
Beyond the preview
Go deeper on NCT02738073.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02738073.